Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer

Fig. 1

The expression of Gal-3 in vitro and in vivo. A Expression of Gal-3 in drug-resistant colon cancer tissue and normal colon tissue of mice. B Semi-quantitative statistical results of Gal-3 expression in drug-resistant colon cancer tissue and normal colon tissue. C The expression of Gal-3 in NCM460 cell, HCT116 cell, HCT116/Fu cell, HCT116/L cell, HT-29 cell and SW620 cell detected by western blot. D The distribution of Gal-3 in NCM460 cell, HCT116 cell, HCT116/Fu cell, HCT116/L cell, HT-29 cell and SW620 cell observed by LSCM. All data are expressed as mean ± SD (n = 3). **p < 0.01 vs normal colon tissue; ##p < 0.01 vs NCM460 cell

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us